• 1
    Sant M,Aareleid T,Berrino F,Bielska LM,Carli PM,Faivre J,Grosclaude P,Hedelin G,Matsuda T,Moller H,Moller T,Verdecchia A, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94—results and commentary. Ann Oncol 2003; 14 ( Suppl 5): v61v118.
  • 2
    Berrino F,Gatta G. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer 1998; 34: 215461.
  • 3
    Ogden GR. Second malignant tumours in head and neck cancer. BMJ 1991; 302: 19394.
  • 4
    Jones AS,Morar P,Phillips DE,Field JK,Husband D,Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995; 75: 134353.
  • 5
    Leon X,Quer M,Diez S,Orus C,Lopez-Pousa A,Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck 1999; 21: 20410.
  • 6
    Giefing M,Rydzanicz M,Szukala K,Wozniak A,Wierzbicka M,Szyfter K,Kujawski M. Second primary tumors (SPT) of head and neck: distinguishing of “true” SPT from micrometastasis by LOH analysis of selected chromosome regions. Neoplasma 2005; 52: 37480.
  • 7
    Ferlay J,Bray F,Pisani P,Parkin DM. Globcan 2002: Cancer incidence, mortality, and prevalence worldwide. IARC Cancer Base No. 5(2). Lyon, France: IARC Press, 2004.
  • 8
    Boice JD,Jr.,Storm HH,Curtis RE,Jensen OM,Kleinerman RA,Jensen HS,Flannery JT,Fraumeni JF,Jr. Introduction to the study of multiple primary cancers. Natl Cancer Inst Monogr 1985; 68: 39.
  • 9
    Veli EM,Schatzkin A. Common environmental risk factors. In: NeugutAI,MeadowsAT,RobinsonE, eds. Multiple primary cancers. Philadelphia: Lippincott Williams & Wilkins, 1999. 21323.
  • 10
    Travis LB. The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 2006; 15: 202026.
  • 11
    Scelo G,Boffetta P,Hemminki K,Pukkala E,Olsen JH,Andersen A,Tracey E,Brewster DH,McBride ML,Kliewer EV,Tonita JM,Pompe-Kirn V, et al. Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer 2006; 118: 18996.
  • 12
    Brennan P,Scelo G,Hemminki K,Mellemkjaer L,Tracey E,Andersen A,Brewster DH,Pukkala E,McBride ML,Kliewer EV,Tonita JM,Seow A, et al. Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma. Br J Cancer 2005; 93: 15966.
  • 13
    Parkin DM,Whelan SL,Ferlay J,Teppo L,Thomas DB. Cancer incidence in five continents. (8). Lyon: IARC, 2002.
  • 14
    Mayne ST,Morse DE,Winn DM. Cancers of the oral cavity and pharynx. In: SchottenfeldD,FraumeniJF,Jr, eds. Cancer epidemiology and prevention,third edition. New York: Oxford University Press, Inc, 2006. 67496.
  • 15
    Scelo G,Boffetta P,Corbex M,Chia KS,Hemminki K,Friis S,Pukkala E,Weiderpass E,McBride ML,Tracey E,Brewster DH,Pompe-Kirn V, et al. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control 2007; 18: 26978.
  • 16
    Muir CS,Percy C. Classification and coding for neoplasms. In: JensenOM,ParkinDM,MacLennanR,MuirCS,SkeetRG, eds. Cancer registration: principles and methods. Lyon: IARC, 1991. 6481.
  • 17
    IARC Working Group. Tobacco smoke and involuntary smoking. IARC 2004; 83: 11438.
  • 18
    Boffetta P,Hashibe M. Alcohol and cancer. Lancet Oncol 2006; 7: 14956.
  • 19
    Vaamonde P,Martin C,del Rio M,LaBella T. Second primary malignancies in patients with cancer of the head and neck. Otolaryngol Head Neck Surg 2003; 129: 6570.
  • 20
    Dhooge IJ,De Vos M,Van Cauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 1998; 108: 25056.
  • 21
    Sturgis EM,Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995; 104: 94654.
  • 22
    Haughey BH,Gates GA,Arfken CL,Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992; 101: 10512.
  • 23
    Slaughter DP,Southwick HW,Smejakl W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953; 6: 96368.
  • 24
    Tomek MS,McGuirt WF. Second head and neck cancers and tobacco usage. Am J Otolaryngol 2003; 24: 2427.
  • 25
    Castigliano SG. Influence of continued smoking on the incidence of second primary cancers involving mouth, pharynx, and larynx. J Am Dent Assoc 1968; 77: 58085.
  • 26
    Goldstein DP,Irish JC. Head and neck squamous cell carcinoma in the young patient. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 20711.
  • 27
    Llewellyn CD,Johnson NW,Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Oral Oncol 2001; 37: 40118.
  • 28
    Verschuur HP,Irish JC,O'Sullivan B,Goh C,Gullane PJ,Pintilie M. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope 1999; 109: 24958.
  • 29
    Sturgis EM,Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110: 142935.
  • 30
    El Mofty SK,Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2003; 27: 146370.
  • 31
    Rose Ragin CC,Taioli E. Second primary head and neck tumor risk in patients with cervical cancer—SEER data analysis. Head Neck 2008; 30: 5866.
  • 32
    Frisch M,Biggar RJ. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 1999; 354: 144243.
  • 33
    Braakhuis BJ,Tabor MP,Leemans CR,van dW, I,Snow GB,Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002; 24: 198206.
  • 34
    Begg CB,Zhang ZF,Sun M,Herr HW,Schantz SP. Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the surveillance, epidemiology, and end results (SEER) program. Am J Epidemiol 1995; 142: 65365.